罗普斯金(002333.SZ)最新公告称，公司拟以现金1.02亿元收购中城绿脉（湖北）检测有限公司65%股 权，交易完成后，中城绿脉将成为公司控股子公司，纳入上市公司合并报表范围。 公告显示，本次交易标的为为国家电梯检测标准核心起草单位，拥有电梯、起重机械、压力容器等全品 类检测资质，在华中区域具备显著品牌与客户优势。公司表示，本次收购将与旗下苏州方正检测形成业 务互补，快速扩张全国检测网络。评估机构对中城绿脉的股东全部权益价值评估为1.57亿元，增值率 531.96%。 同日公布的第六届董事会第二十三次会议决议公告称，为增强公司科技属性，促进业务的多元化发展， 公司以自有现金人民币882.28万元，以增资扩股方式收购武汉森福瑞科技有限公司38.38%股权，本次增 资完成后，公司成为其参股股东。 森福瑞是一家专注于工业无损检测设备的研发、生产及销售的高新技术企业，主要产品涵盖磁粉探伤 机、手动扫查器等，广泛应用于电力、新能源汽车、特种设备、建筑与桥梁等多个领域。 两起并购完成后，罗普斯金将完成从铝型材制造商向"材料+检测"双轮驱动企业的战略升级。 公司称，后续随着标的公司经营水平逐步向好，将有助于增强公司的持 ...

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets announced significant updates, reflecting changes in capital raising strategies, new business ventures, and financial performance for the first half of the year [1][2]. Company Announcements - Shennong Group has decided to terminate its plan for a specific stock issuance for the 2024 fiscal year due to changes in market conditions and overall development strategy, and will withdraw its application from the Shanghai Stock Exchange [3]. - Xizhuang Co. plans to establish a joint venture focused on sustainable aviation fuel, contributing 1.1 million yuan to a total registered capital of 5 million yuan, aiming to expand its technology into new application areas [4]. - Shandong Gold's subsidiary, Shanjin International, intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange, considering market conditions and shareholder interests [5]. - Lopuskin plans to acquire a 38.38% stake in Wuhan Senfori Technology Co. for 8.82 million yuan, enhancing its position in the industrial non-destructive testing equipment sector [6]. - Hengxin Life intends to invest up to 505 million yuan in a biodegradable product production base in Hefei, Anhui Province [7]. - Hetai Machinery confirmed it has not participated in the Yarlung Zangbo River downstream hydropower project, which is still in the early stages of construction [8]. - Kaishan Co. plans to acquire a 5% stake in Sorik Marapi Geothermal Limited in Indonesia for 3 million USD, aiming for full ownership [9][10]. Financial Performance - WuXi AppTec reported a net profit of 8.561 billion yuan for the first half of 2025, a year-on-year increase of 101.92%, with revenue of 20.799 billion yuan, up 20.64% [12]. - Sujiao Technology's net profit decreased by 39.54% year-on-year to 95.3948 million yuan, with revenue down 13.75% to 1.776 billion yuan [13]. - Aide Biology achieved a net profit of 189 million yuan, a 31.41% increase year-on-year, with revenue of 579 million yuan, up 6.69% [14]. Major Contracts - Weiye Co. won a construction project worth approximately 522 million yuan for the Huafa Xiangshan Lake project [16]. - Fosun Pharma's subsidiary signed a licensing agreement for a drug targeting Alzheimer's disease, gaining rights for development and commercialization in China and Hong Kong [17]. - Huafeng Aluminum plans to sign a raw material purchase contract with Yulin New Materials, with an expected total value exceeding 7.2 billion yuan over the contract period from 2025 to 2029 [18]. Shareholding Changes - Suneng Co.'s shareholder, Jiaoyin Investment, plans to reduce its stake by up to 1%, amounting to no more than 6.8888 million shares [20]. - Shengyang Technology's shareholder, Guojiao Beidou, also intends to reduce its stake by up to 1%, equating to no more than 414.98 million shares [22]. Fundraising Activities - Huhua Co. plans to raise up to 586 million yuan through a private placement to fund various projects, including the automation of explosive production lines and warehouse systems [24].